Capricor Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update

Go back to Capricor Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update

Capricor Therapeutics (CAPR) Reports Q4 Loss of $0.21/Share

March 15, 2017 4:25 PM EDT

Capricor Therapeutics (NASDAQ: CAPR) reported Q4 EPS of ($0.21), versus ($0.21) reported last year.

For earnings history and earnings-related data on Capricor Therapeutics (CAPR) click here.

... More